Jovanovic A et al. Large-scale testing of antimicrobial lethality at single-cell resolution predicts mycobacterial infection outcomes. Nat Microbiol. 2026;11(2):566-583. DOI: 10.1038/s41564-025-02217-y
March V.F.A et al. Within-host evolution of drug tolerance in Mycobacterium tuberculosis. JAC Antimicrob Resist. 2026;8(1):dlag007. DOI: 10.1093/jacamr/dlag007
Arbués A, Schmidiger S, Reinhard M, Borrell S, Gagneux S, Portevin D. Soluble immune mediators orchestrate protective in vitro granulomatous responses across Mycobacterium tuberculosis complex lineages. Elife. 2025;13:RP99062. DOI: 10.7554/eLife.99062
Goig G.A et al. Transmission as a key driver of resistance to the new tuberculosis drugs. N Engl J Med. 2025;392(1):97-99. DOI: 10.1056/NEJMc2404644
Goig G.A et al. Clinical and bacterial determinants of unfavorable tuberculosis treatment outcomes: an observational study in Georgia. Genome Med. 2025;17:143. DOI: 10.1186/s13073-025-01555-0
Goig G.A et al. Ecology, global diversity and evolutionary mechanisms in the Mycobacterium tuberculosis complex. Nat Rev Microbiol. 2025;23(9):602-614. DOI: 10.1038/s41579-025-01159-w
Maghradze N et al. Linking genetic and phenotypic bedaquiline resistance in Mycobacterium tuberculosis strains from Georgia. PLoS One. 2025;20(7):e0326794. DOI: 10.1371/journal.pone.0326794
March V.F.A et al. Drug-induced differential culturability in diverse strains of Mycobacterium tuberculosis. Sci Rep. 2025;15:3588. DOI: 10.1038/s41598-024-85092-7
March V.F.A et al. Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage. Antimicrob Agents Chemother. 2025;69(12):e0099625. DOI: 10.1128/aac.00996-25
Rojas V.M.R, Zwyer M, Bouaouina S, Brites D, Borrell S, Gagneux S. Mycobacterium tuberculosis complex Lineage 1: A neglected cause of tuberculosis. PLoS Negl Trop Dis. 2025;19(10):e0013513. DOI: 10.1371/journal.pntd.0013513